Wal­mart is ex­pand­ing its vir­tu­al care ben­e­fits na­tion­al­ly af­ter see­ing it re­duced health­care costs by 11%

Last year
Health Tech

BioN­Tech sends $70M to an­oth­er ADC part­ner to go up against Dai­ichi Sankyo in HER3

Last year
Deals
China

#Eu­ro­Bio23: The down­turn, tak­ing risks and the ‘biotech mafia’

Last year
People
Financing

As­tria nabs pre­clin­i­cal OX40 atopic der­mati­tis drug for $15M up­front, prices $64M of­fer­ing

Last year
Financing
Deals

Alvotech’s Reyk­javik man­u­fac­tur­ing dol­drums con­tin­ue with CRL for Ste­lara biosim­i­lar

Last year
FDA+
Manufacturing

Il­lu­mi­na re­ceives EU or­der to di­vest Grail

Last year
Deals
Diagnostics

Delaware judge ap­proves Mallinck­rodt's sec­ond bank­rupt­cy plan since 2020

Last year
Pharma

Bio­gen cuts al­most one-third of Reata's staff fol­low­ing $7B buy­out

Last year
People
Pharma

Su­per­nus drafts NFL sports­cast­er in me­dia and so­cial blitz for AD­HD med Qel­bree

Last year
Pharma
Marketing

GSK set­tles an­oth­er heart­burn drug Zan­tac can­cer case in Cal­i­for­nia, does­n't ad­mit li­a­bil­i­ty

Last year
Pharma
Law

CMS post­pones na­tion­al cov­er­age de­ter­mi­na­tion for PrEP, says de­ci­sion is 'forth­com­ing'

Last year
Pharma
FDA+

Sanofi and Har­ris Poll glob­al he­mo­phil­ia study finds ‘trou­bling dis­con­nect’ be­tween pa­tients and providers

Last year
Pharma
Marketing

Mod­er­na's new Covid-19 vac­cine analy­sis 'giv­ing weight' to an­nu­al boost­ing in­ter­val, com­pa­ny says

Last year
Pharma
Coronavirus

Hu­mana CEO Bruce Brous­sard is step­ping down next year

Last year
Health Tech

Wal­greens hires long­time Cigna ex­ec­u­tive Tim Went­worth as CEO

Last year
People
Health Tech

CRO at cen­ter of Pfiz­er’s Ly­me vac­cine study woes says FDA found no tri­al mis­con­duct 

Last year
R&D
Pharma

FDA launch­es new dig­i­tal health ad­comm to tack­le in­com­ing com­plex­i­ties

Last year
AI
FDA+

FDA hits New Jer­sey API man­u­fac­tur­er with 14 de­fi­cien­cies across three sites in Form 483

Last year
Pharma
FDA+

eGe­n­e­sis brings kid­ney xeno­trans­plants clos­er to the clin­ic

Last year
R&D
Cell/Gene Tx

Mi­cro­bio­me start­up sells off as­sets; Faron's PhI/II da­ta in bone mar­row can­cer; AM Phar­ma touts bio­mark­er re­sults

Last year
R&D
News Briefing

Dan­ish biotech gears up for Phase IIb hidradeni­tis sup­pu­ra­ti­va tri­al fol­low­ing ear­ly clin­i­cal re­sults

Last year
R&D

Tem­pest eyes piv­otal tri­al for liv­er can­cer drug af­ter un­veil­ing ear­ly PFS, OS da­ta

Last year
R&D

Ex­clu­sive: Liq­uid-biop­sy start­up clos­es $17M to fund ovar­i­an can­cer di­ag­nos­tic test

Last year
Financing
Diagnostics

No­vo stops late-stage kid­ney tri­al for semaglu­tide ear­ly for ef­fi­ca­cy, da­ta com­ing in 2024

Last year
R&D
First page Previous page 265266267268269270271 Next page Last page
A service from the Financial Times